Pharma Marketing News
Pharma Marketing News Subscribe Glossary Daily Pharma News Feeds
Pharma Marketing Blog Discussion Forums Audio Podcasts Conference Calendar Reader Surveys

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
Share |

The FTC-Lilly Consent Decree
What it Means for PHARMA Vendors and Partners

The 2002 settlement between ELi Lilly and the FTC regarding "unauthorized disclosure of sensitive personal information collected from consumers" has an impact beyond Lilly. It also affects its agents who collect personally identifiable information from consumers in "connection with the advertising, marketing, offering for sale, or sale of any pharmaceutical product."

Such agents could include interactive agencies that build and maintain Web sites, direct marketing agencies, fulfillment centers, market researchers, etc.

If you are a pharmaceutical service provider, read this commentary to learn what you need to do to be compliant with privacy and security standards demanded by your pharma clients.

Read this article now. It's FREE...

Download PDF file

PMN211-03
Issue: Vol. 2, No. 10: December 2003

Word Count: n/a

Find other articles in related Topic Areas:

Vol 2, #11 Contents









Search All Pharma Marketing News Pages

Pharma Marketing News Email Addr:  

Contact Information
Editor
Pharma Marketing News


Pharma Marketing News | Subscribe | Discussion Forums | Podcasts | Blog
Daily News Briefs | Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2013. VirSci Corporation. All rights reserved.